Mucinous, endometrioid, and serous ovarian cancers with peritoneal dissemination are potent candidates for P-cadherin targeted therapy: a retrospective cohort study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Mucinous, endometrioid, and serous ovarian cancers with peritoneal dissemination are potent candidates for P-cadherin targeted therapy: a retrospective cohort study ; volume:21 ; number:1 ; day:7 ; month:1 ; year:2021 ; pages:1-9 ; date:12.2021
BMC cancer ; 21, Heft 1 (7.1.2021), 1-9, 12.2021
- Creator
-
Kayahashi, Kayo
Mizumoto, Yasunari
Matsuoka, Ayumi
Obata, Takeshi
Iwadare, Junpei
Nakamura, Mitsuhiro
Daikoku, Takiko
Fujiwara, Hiroshi
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-020-07737-w
- URN
-
urn:nbn:de:101:1-2021020802360997544353
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kayahashi, Kayo
- Mizumoto, Yasunari
- Matsuoka, Ayumi
- Obata, Takeshi
- Iwadare, Junpei
- Nakamura, Mitsuhiro
- Daikoku, Takiko
- Fujiwara, Hiroshi
- SpringerLink (Online service)
Other Objects (12)
MRI for differentiating ovarian endometrioid adenocarcinoma from high-grade serous adenocarcinoma
Noncommunicating cystic pancreatic lesions (i.e. serous and mucinous cystadenoma + rare lesions)
Abdominopelvic Metastasis of Endometrial Serous Carcinoma Initially Misdiagnosed as Early-Stage Low-Grade Endometrioid Carcinoma: The Importance of Recognizing Minimal Uterine Serous Carcinoma
STK4 protein expression pattern follows different trends in endometrioid and serous endometrial adenocarcinoma upon tumor progression
Comparison of stage III mucinous and serous ovarian cancer: a case-control study
Chemotherapy is not necessary for early-stage serous and endometrioid ovarian cancer after undergoing comprehensive staging surgery
Endometrioid adenocarcinoma with simultaneous endocervical and intestinal-type mucinous differentiation: report of a rare phenomenon and the immunohistochemical profile
EZH2 inhibition in ARID1A mutated clear cell and endometrioid ovarian and endometrioid endometrial cancers
Serous
CBX2 identified as driver of anoikis escape and dissemination in high grade serous ovarian cancer
Deciphering tumor immune microenvironment differences between high-grade serous and endometrioid ovarian cancer to investigate their potential in indicating immunotherapy response
Retrorectal endometrioid cyst: a case report
MRI for differentiating ovarian endometrioid adenocarcinoma from high-grade serous adenocarcinoma
Noncommunicating cystic pancreatic lesions (i.e. serous and mucinous cystadenoma + rare lesions)
Abdominopelvic Metastasis of Endometrial Serous Carcinoma Initially Misdiagnosed as Early-Stage Low-Grade Endometrioid Carcinoma: The Importance of Recognizing Minimal Uterine Serous Carcinoma
STK4 protein expression pattern follows different trends in endometrioid and serous endometrial adenocarcinoma upon tumor progression
Comparison of stage III mucinous and serous ovarian cancer: a case-control study
Chemotherapy is not necessary for early-stage serous and endometrioid ovarian cancer after undergoing comprehensive staging surgery
Endometrioid adenocarcinoma with simultaneous endocervical and intestinal-type mucinous differentiation: report of a rare phenomenon and the immunohistochemical profile
EZH2 inhibition in ARID1A mutated clear cell and endometrioid ovarian and endometrioid endometrial cancers
Serous
CBX2 identified as driver of anoikis escape and dissemination in high grade serous ovarian cancer
Deciphering tumor immune microenvironment differences between high-grade serous and endometrioid ovarian cancer to investigate their potential in indicating immunotherapy response
Retrorectal endometrioid cyst: a case report
MRI for differentiating ovarian endometrioid adenocarcinoma from high-grade serous adenocarcinoma
Noncommunicating cystic pancreatic lesions (i.e. serous and mucinous cystadenoma + rare lesions)
Abdominopelvic Metastasis of Endometrial Serous Carcinoma Initially Misdiagnosed as Early-Stage Low-Grade Endometrioid Carcinoma: The Importance of Recognizing Minimal Uterine Serous Carcinoma
STK4 protein expression pattern follows different trends in endometrioid and serous endometrial adenocarcinoma upon tumor progression
Comparison of stage III mucinous and serous ovarian cancer: a case-control study
Chemotherapy is not necessary for early-stage serous and endometrioid ovarian cancer after undergoing comprehensive staging surgery
Endometrioid adenocarcinoma with simultaneous endocervical and intestinal-type mucinous differentiation: report of a rare phenomenon and the immunohistochemical profile
EZH2 inhibition in ARID1A mutated clear cell and endometrioid ovarian and endometrioid endometrial cancers
Serous
CBX2 identified as driver of anoikis escape and dissemination in high grade serous ovarian cancer
Deciphering tumor immune microenvironment differences between high-grade serous and endometrioid ovarian cancer to investigate their potential in indicating immunotherapy response